Washington University Institute of Clinical and Translational Sciences
华盛顿大学临床与转化科学研究所
基本信息
- 批准号:10598597
- 负责人:
- 金额:$ 1017.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-19 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAdoptedAdvocateAffectBiologicalBiometryClinicClinicalClinical ResearchClinical SciencesClinical TrialsClinical and Translational Science AwardsCollaborationsCommunitiesCommunity HealthComplexConceptionsData SetDevelopmentDiseaseDissemination and ImplementationEcosystemEducationElderlyEnsureFacultyGenomicsGoalsHealthHealthcareHealthcare SystemsHomeHumanIllinoisIndividualIndustryInequityInformaticsInfrastructureInstitutionInterdisciplinary StudyInterventionKnowledgeLaboratoriesLifeLongevityMentorsMethodologyMethodsMissouriMulti-Institutional Clinical TrialOutcomeParticipantPatient CarePatientsPopulationPopulation HeterogeneityProcessProductivityQualifyingResearchResearch PersonnelResourcesRural PopulationScienceSocioeconomic FactorsSpecial PopulationTarget PopulationsTechnologyTimeTrainingTraining ProgramsTranslatingTranslational ResearchTranslationsUniversitiesUrban PopulationWashingtonWorkWorkforce Developmentarchived databaseclinical practicecommunity engagementdata integrationdigitaldissemination sciencediverse dataeducation researchfundamental researchhealth differencehealth disparityhealth inequalitiesimplementation designimplementation scienceimprovedinformatics toolinnovationinter-institutionalinteroperabilitymultidisciplinarymultiscale dataprogramsrural environmentskillssocial determinantstranslational impacturban setting
项目摘要
Contact PD/PI: Powderly, William G.
Overall Component, 7. Project Summary/Abstract:
The Institute of Clinical and Translational Sciences aligns with the CTSA goals of developing innovative
solutions to improve the efficiency, quality, and impact of translational science. We will pursue five aims:
Aim 1: Advance interdisciplinary programs to develop, promote, mentor, and retain highly qualified
and diverse faculty, trainees, and staff who translate scientific discoveries into action, thereby
becoming agents for change in their institutions and communities. We will enhance our existing research
education and training programs, expand and diversify our workforce, and promote team science approaches
to conduct and translate high-impact research that has the potential for changing the health of our community.
(Translational Workforce Development).
Aim 2: Facilitate research designed for implementation by engaging diverse communities and
stakeholders in multidisciplinary collaborative teams at all stages of the translational research
process, thereby demonstrating the benefit and impact of translational science. We will improve
community health by collaborating with patient advocates, developing new partnerships, advancing the science
of collaboration, and capitalizing on strengths in implementation science (Collaboration and Engagement).
Aim 3: Integrate research across individual lifespans and apply translational science in complex and
diverse populations to improve individual and community health through meaningful research
collaborations and sustainable partnerships. We will address health disparities across the lifespan and
among special populations, identify challenges that differentially affect urban and rural populations, catalyze
the formation of transdisciplinary teams, and evaluate the outcomes of our work (Integration).
Aim 4: Drive innovation, quality, efficiency, and inclusion in translational research to enhance
collaborations and catalyze the implementation of discovery science. We will solve key logistical
roadblocks in translational science and implement innovative methods to engage stakeholders and research
participants, thereby targeting different populations, life stages, and health states (Methods and Processes).
Aim 5: Apply innovative informatics and biostatistics solutions to improve quality and efficiency at
every stage of translational research, and create an ecosystem that integrates diverse data and
facilitates the interoperability, use, and reuse of digital assets. We will ensure the interoperability of
current and archived data sets, implement new informatics technologies to enhance investigator productivity,
and promote the formation of interdisciplinary research teams (Informatics).
Impact. Successful completion of these five aims will transform translational research, accelerate the
dissemination of new innovations across our entire population, and strengthen and diversify our workforce.
Project Summary/Abstract Page 235
Contact PD/PI: Powderly, William G.
Overall Component
8.
联系PD/PI:粉状,William G.
总体组件,7。项目摘要/摘要:
临床和转化科学研究所与开发创新的CTSA目标保持一致
提高转化科学效率,质量和影响的解决方案。我们将追求五个目标:
目标1:提前跨学科计划,以开发,促进,指导和保留高素质
以及将科学发现转化为行动的多元化教师,学员和员工
成为其机构和社区变革的代理商。我们将增强现有研究
教育和培训计划,扩大和多样化我们的劳动力,并促进团队科学方法
进行和翻译高影响力的研究,有可能改变我们社区的健康状况。
(转化劳动力发展)。
目标2:通过参与多元化社区和
转化研究各个阶段的多学科合作团队的利益相关者
过程,从而证明了翻译科学的好处和影响。我们将有所改善
通过与患者倡导者合作,建立新的伙伴关系并推进科学来通过合作进行社区健康
协作,并利用实施科学的优势(协作和参与)。
目标3:整合跨个体寿命的研究,并将转化科学应用于复杂的和
通过有意义的研究来改善个人和社区健康的多样化人群
合作和可持续合作伙伴关系。我们将解决整个生命周期的健康差异
在特殊人群中,确定影响城市和农村人口差异的挑战,催化
跨学科团队的形成,并评估我们工作的结果(集成)。
目标4:推动创新,质量,效率和包容性转化研究以增强
合作和催化发现科学的实施。我们将解决关键后勤
转化科学中的障碍并实施创新方法,以吸引利益相关者和研究
参与者,从而针对不同的人群,生活阶段和健康状况(方法和过程)。
目标5:应用创新的信息学和生物统计学解决方案来提高质量和效率
翻译研究的每个阶段,创建一个整合多种数据和的生态系统
促进数字资产的互操作性,使用和再利用。我们将确保互操作性
当前和存档的数据集,实施新的信息学技术来提高研究者的生产率,
并促进跨学科研究团队的形成(信息学)。
影响。这五个目标的成功完成将改变转化研究,加速
在整个人群中传播新的创新,并增强和多样化我们的员工队伍。
项目摘要/摘要页面235
联系PD/PI:粉状,William G.
总体组件
8。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William G. Powderly其他文献
Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031.
三甲曲沙联合甲酰四氢叶酸与甲氧苄氨嘧啶-磺胺甲恶唑治疗艾滋病患者中度至重度卡氏肺孢子虫肺炎发作:艾滋病临床试验组方案 029/031 的一项前瞻性、对照多中心研究。
- DOI:
10.1093/infdis/170.1.165 - 发表时间:
1994 - 期刊:
- 影响因子:0
- 作者:
Fred R. Sattler;Peter T. Frame;R. Davis;Larry Nichols;Brent Shelton;B. Akil;Robert P. Baughman;C. Hughlett;Walter Weiss;C. Boylen;C. V. D. Horst;John H. Black;William G. Powderly;Roy T. Steigbigel;J. Leedom;Henry Masur;Judith Feinberg - 通讯作者:
Judith Feinberg
Cyclic AMP Cyclic GMP VASCULAR tone isregulated by a variety of vasoactive mol cules : neurotransmitters
Cyclic AMP Cyclic GMP 血管张力受多种血管活性分子:神经递质调节
- DOI:
- 发表时间:
2008 - 期刊:
- 影响因子:0
- 作者:
P. Tebas;A. Patick;E. Kane;Michael Klebert;Janet H. Simpson;Alejo Erice;William G. Powderly;Keith Henry - 通讯作者:
Keith Henry
When to start antiretroviral therapy: asking the right question
何时开始抗逆转录病毒治疗:提出正确的问题
- DOI:
10.2217/fvl.11.26 - 发表时间:
2011 - 期刊:
- 影响因子:3.1
- 作者:
William G. Powderly - 通讯作者:
William G. Powderly
Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.
先前奈非那韦治疗失败的患者对含利托那韦-沙奎那韦疗法的病毒学反应。
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
P. Tebas;A. Patick;E. Kane;Michael Klebert;Janet H. Simpson;Alejo Erice;William G. Powderly;Keith Henry - 通讯作者:
Keith Henry
Efficacy of Infliximab, Abatacept, and Cenicriviroc for the Treatment of Adults Hospitalized with COVID-19 Pneumonia
英夫利昔单抗、阿巴西普和西尼立韦罗治疗因 COVID-19 肺炎住院的成人的疗效
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:8.4
- 作者:
Dan;Jianqiao Wang;Kevin J. Anstrom;Lisa M. LaVange;Jun Wen;Samuel A. Bozzette;William G. Powderly - 通讯作者:
William G. Powderly
William G. Powderly的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William G. Powderly', 18)}}的其他基金
Washington University Institute of Clinical and Translational Sciences
华盛顿大学临床与转化科学研究所
- 批准号:
10827727 - 财政年份:2023
- 资助金额:
$ 1017.84万 - 项目类别:
Washington University Institute of Clinical and Translational Sciences
华盛顿大学临床与转化科学研究所
- 批准号:
10700256 - 财政年份:2022
- 资助金额:
$ 1017.84万 - 项目类别:
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES
华盛顿大学临床与转化科学研究所
- 批准号:
10321102 - 财政年份:2017
- 资助金额:
$ 1017.84万 - 项目类别:
Washington University Institute of Clinical and Translational Sciences
华盛顿大学临床与转化科学研究所
- 批准号:
10556449 - 财政年份:2017
- 资助金额:
$ 1017.84万 - 项目类别:
Washington University Institute of Clinical Translational Sciences
华盛顿大学临床转化科学研究所
- 批准号:
9889200 - 财政年份:2017
- 资助金额:
$ 1017.84万 - 项目类别:
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES
吴氏临床与转化科学研究所
- 批准号:
10217859 - 财政年份:2017
- 资助金额:
$ 1017.84万 - 项目类别:
Rosiglitazone & Exercise Training: Effects on HIV-Infected People
罗格列酮
- 批准号:
6971952 - 财政年份:2004
- 资助金额:
$ 1017.84万 - 项目类别:
STUDY OF ONCE-WEEKLY ALENDRONATE IN HIV-INFECTED SUBJECTS
HIV 感染者每周一次阿仑膦酸钠的研究
- 批准号:
6971984 - 财政年份:2004
- 资助金额:
$ 1017.84万 - 项目类别:
WU 122: EVALUATE METABOLIC EFFECTS OF DISCONTINUATION OF ANTIRETROVIRAL THERAPY
WU 122:评估停止抗逆转录病毒治疗的代谢影响
- 批准号:
6971971 - 财政年份:2004
- 资助金额:
$ 1017.84万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Creation of a knowledgebase of high quality assertions of the clinical actionability of somatic variants in cancer
创建癌症体细胞变异临床可行性的高质量断言知识库
- 批准号:
10555024 - 财政年份:2023
- 资助金额:
$ 1017.84万 - 项目类别:
Accelerated Neuromodulation of Prefrontal Circuitry during Clozapine Treatment
氯氮平治疗期间前额叶回路的加速神经调节
- 批准号:
10726660 - 财政年份:2023
- 资助金额:
$ 1017.84万 - 项目类别:
Unified, Scalable, and Reproducible Neurostatistical Software
统一、可扩展且可重复的神经统计软件
- 批准号:
10725500 - 财政年份:2023
- 资助金额:
$ 1017.84万 - 项目类别:
The WUSTL PREP post-bacc program to enhance doctoral readiness in neuroscience
WUSTL PREP post bacc 项目旨在提高神经科学博士的准备程度
- 批准号:
10611674 - 财政年份:2023
- 资助金额:
$ 1017.84万 - 项目类别: